RE: Singer20 Jan 2025 10:13
Singer’s estimates are, for FY24, 25 and 26:
Revenue: 53.4, 60.1, 65.6
EBITDA: 15.2, 17.1, 19.0
EV/EBITDA: 7.2, 6.3, 5.5
These seem very cautious to me. Their ARR figures, which have increased by $3.8m and $5.2m in the last two years, increase by only $3m in 2025 and 2026. This is counterintuitive as you’d expect continued growth from existing business (ARR if $14.0m) to be at least around that figure by itself (ie increased by the NRR). They note that there is good visibility of 2025 DVM figures just from the existing ARR.
They note there is an expectation of an increase in gross margins but there are exceptional costs associated.
They note the valuation gap to Boku, which is trading on 5.4 EV/sales compared to BGO 2.1x.
Overall they think the results are very reassuring, provide a good foundation for growth and there is potentially material upside to their 220p price target.